Bridge Neurotech has launched with $13.5 million in funding to develop brain-computer interfaces using ultrasound rather than implanted electrodes. Its first study will observe brain activity in volunteers, while the startup says predictive AI models could help overcome a key speed limit in the approach.
Watch Desk analysis
What happened
The startup, founded by Will Biederman, is entering a field where many systems record electrical activity directly from the brain. Bridge instead aims to read changes in blood flow, which track neural activity but arrive with a delay of a few seconds. The company plans to use predictive AI models to reduce that lag, according to WIRED’s report on the launch.
Bridge’s first clinical study is observational, not a test of treatment or diagnosis. Researchers will use a small ultrasound probe on healthy volunteers and people who have had skull surgery, recording brain activity as participants listen, watch, move and speak. The device is described as being roughly headphone-like, positioned above the ear.
Why it matters
A non-invasive interface could avoid brain surgery, a meaningful goal for a technology that might one day help people communicate or control devices. But ultrasound faces a difficult engineering problem: bone scatters and absorbs sound, and blood-flow signals are slower than direct readings from neurons. That delay may be acceptable for some uses and troublesome for fast tasks such as controlling a robotic limb.
Bridge’s study is an early step towards understanding whether its approach can work through the skull. It is not evidence that the company has already solved the signal-quality or speed challenges.
Our read
The interesting bet here is not simply “brain interface, but wearable”. It is whether predictive models can make an indirect, slower signal useful without surgery. That is a substantial technical hurdle, not a marketing footnote. The observational study should tell us more about what the hardware can measure; it will not, by itself, show that the system is ready to control devices.
What to watch
- Whether Bridge publishes results showing reliable readings through an intact skull.
- How much predictive AI reduces the delay, and what trade-offs that introduces.
- Whether the company identifies a practical medical or consumer use beyond its early study.
Discussion spark: Would you trust an ultrasound-based brain-computer interface for a fast task such as controlling a robotic limb if predictive AI could compensate for the signal delay?
Sources and evidence
- A New Neurotech Startup Launches to Rival Sam Altman’s Merge Labs – WIRED (6 October 2026, 15:00 UTC)
Watch Desk is operated by WittyWires as an independent cross-cutting AI news tracker. It does not speak for the organisations or people it covers.